Snowball logo
logo
CYCC_logo

Cyclacel Pharmaceuticals Inc

CYCC β€’ NASDAQ
$6.365-$0.405Β  (5.98%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20202021202220232024TTM
Revenue
Total revenue
0.005877-0.3730.420.043(0.025)
COGS
0.020.0430.0320.0320.006-
Gross Profit
(0.02)(0.043)(0.032)0.420.043-
Operating Expenses & Income
Operating Income
(10.64)(22.94)(27.66)(25.45)(12)(10.36)
Total Operating Expenses
10.6422.3927.6625.8712.0510.37
R&D Expenses
4.75914.9320.2719.166.6552.652068
Selling General & Admin Expenses
5.8777.4617.3826.7185.3926.400249
Earnings from Continuing Operations
Interest Expense
(0.997)(0.291)(2.006)(2.006)-(0.000008)
Interest Income
0.0420.0160.210.3650.0120.016
Income Tax Expense
(1.236)(3.847)(4.717)(2.996)(0.782)0.986
Net Income
Net Income
(8.445)(18.89)(21.2)(22.55)(11.21)(6.408)
Supplemental
EBIT
(10.64)(22.73)(27.66)(25.45)(12)(10.36)
EBITDA
(10.62)(22.69)(27.62)(25.42)(12)-
In millions of USD, except % and values per 1 share